Xenodiagnostics

Xenodin is a new method for diagnosing diseases, which involves the use of the drug XEN. This drug was created in collaboration between scientists from the Institute of Physical Problems named after. P.L. Kapitsa RAS commissioned by the pharmaceutical company "Altpharm" and is a copy of real xenon. The use of xenon for xenodiagnosis was discovered in the middle of the 20th century, and in the 21st century this method is already widely used in medicine. Due to its unique properties, xenoblocking activates protein synthesis in tumor cells and prevents the initiation of apoptosis and metastasis. The inclusion of Xenodid in the diet leads to a decrease in the level of tumor necrosis factor (TNF) in the blood, which helps prevent the development of cancer and reduce the risk of relapse. Such processes lead to the fact that the body begins to independently fight the disease and increase the number of autoantibodies to the maximum level. Moreover, the duration of treatment for xenodiagnosis is significantly less than that of other treatment methods. Under such conditions, XEN begins to stimulate the production of growth factors, due to which, under the influence of Xenodide, cells are able to mutate into healthy ones. Alternatively, point changes in DNA and the appearance of new chromosomal regions may be observed.

When diagnosing with xenoid, many diseases are detected, for example, ulcerative colitis, colon cancer, melanoma and others. The drug is highly effective and provides quick results - a blood test can be performed within 15 minutes after taking the drug. Research has also revealed the possibility of diagnosing hepatitis and other liver diseases, thyroid dysfunction